Kevin Caliendo
Stock Analyst at UBS
(4.19)
# 459
Out of 4,966 analysts
182
Total ratings
69.84%
Success rate
9.01%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PINC Premier | Maintains: Neutral | $23 → $26 | $25.90 | +0.39% | 2 | Aug 20, 2025 | |
| CVS CVS Health | Upgrades: Buy | $67 → $79 | $73.15 | +8.00% | 9 | Aug 18, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $7 | $4.90 | +42.86% | 6 | Aug 13, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Buy | $25 → $24 | $14.30 | +67.83% | 11 | Aug 8, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $8.5 → $9 | $5.48 | +64.23% | 5 | Aug 8, 2025 | |
| HSIC Henry Schein | Maintains: Neutral | $75 → $70 | $69.58 | +0.60% | 6 | Aug 6, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $22 | $21.18 | +3.87% | 4 | Jul 29, 2025 | |
| MOH Molina Healthcare | Maintains: Neutral | $260 → $180 | $180.83 | -0.46% | 4 | Jul 25, 2025 | |
| LH Labcorp Holdings | Maintains: Buy | $282 → $305 | $277.99 | +9.72% | 4 | Jul 25, 2025 | |
| DGX Quest Diagnostics | Maintains: Neutral | $175 → $180 | $181.64 | -0.90% | 15 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $385 | $309.87 | +24.25% | 12 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $10 | $18.88 | -47.03% | 1 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6 → $5.25 | $4.35 | +20.69% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $9.65 | +55.44% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $9 | $6.90 | +30.43% | 3 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $17 | $16.36 | +3.91% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $170 | $148.78 | +14.26% | 17 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $708 → $805 | $686.64 | +17.24% | 14 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $298 → $335 | $291.61 | +14.88% | 2 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $240 → $215 | $141.96 | +51.45% | 18 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $390 | $300.87 | +29.62% | 11 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $380 → $250 | $303.66 | -17.67% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $29.04 | +172.04% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $318.65 | +80.45% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $177.17 | +1.60% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $7.73 | +831.44% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $18.38 | -40.15% | 4 | May 4, 2021 |
Premier
Aug 20, 2025
Maintains: Neutral
Price Target: $23 → $26
Current: $25.90
Upside: +0.39%
CVS Health
Aug 18, 2025
Upgrades: Buy
Price Target: $67 → $79
Current: $73.15
Upside: +8.00%
Owens & Minor
Aug 13, 2025
Maintains: Buy
Price Target: $13 → $7
Current: $4.90
Upside: +42.86%
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Buy
Price Target: $25 → $24
Current: $14.30
Upside: +67.83%
LifeStance Health Group
Aug 8, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $5.48
Upside: +64.23%
Henry Schein
Aug 6, 2025
Maintains: Neutral
Price Target: $75 → $70
Current: $69.58
Upside: +0.60%
Envista Holdings
Jul 29, 2025
Maintains: Neutral
Price Target: $18 → $22
Current: $21.18
Upside: +3.87%
Molina Healthcare
Jul 25, 2025
Maintains: Neutral
Price Target: $260 → $180
Current: $180.83
Upside: -0.46%
Labcorp Holdings
Jul 25, 2025
Maintains: Buy
Price Target: $282 → $305
Current: $277.99
Upside: +9.72%
Quest Diagnostics
Jul 23, 2025
Maintains: Neutral
Price Target: $175 → $180
Current: $181.64
Upside: -0.90%
Jun 25, 2025
Maintains: Buy
Price Target: $400 → $385
Current: $309.87
Upside: +24.25%
May 15, 2025
Maintains: Neutral
Price Target: $16 → $10
Current: $18.88
Upside: -47.03%
May 13, 2025
Maintains: Neutral
Price Target: $6 → $5.25
Current: $4.35
Upside: +20.69%
May 9, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $9.65
Upside: +55.44%
May 8, 2025
Maintains: Neutral
Price Target: $12 → $9
Current: $6.90
Upside: +30.43%
May 2, 2025
Maintains: Neutral
Price Target: $16 → $17
Current: $16.36
Upside: +3.91%
May 2, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $148.78
Upside: +14.26%
Apr 29, 2025
Maintains: Buy
Price Target: $708 → $805
Current: $686.64
Upside: +17.24%
Apr 29, 2025
Maintains: Buy
Price Target: $298 → $335
Current: $291.61
Upside: +14.88%
Apr 24, 2025
Maintains: Neutral
Price Target: $240 → $215
Current: $141.96
Upside: +51.45%
Feb 3, 2025
Maintains: Buy
Price Target: $410 → $390
Current: $300.87
Upside: +29.62%
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $303.66
Upside: -17.67%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $29.04
Upside: +172.04%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $318.65
Upside: +80.45%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $177.17
Upside: +1.60%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $7.73
Upside: +831.44%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $18.38
Upside: -40.15%